News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

BioSpace News - All
3 Biotechs With Make-or-Break Trial Results, FDA Meetings Coming Soon 9/22/2017
Bay Area's IMPAX Labs (IPXL) Surges on Merger Buzz 9/22/2017
Bay Area Versartis (VSAR)'s Stock Collapses as Growth Hormone Drug Flunks Phase III Test 9/22/2017
BioProcess International Conference Brings Biotech Together in Boston 9/22/2017
Delcath Systems (DCTH) Struggles to Find Ways to Raise Cash and Stay in Business 9/22/2017
19 Deaths, Serious Liver Injury Linked to Intercept Pharma (ICPT)'s Ocaliva 9/22/2017
Recent Cyberattack on Merck & Co. (MRK) Could Lead to Drug Shortage 9/22/2017
Startup Whiz Kid Vivek Ramaswamy Does it Again, Launches Bay Area Firm to Revolutionize Clinical Trials 9/21/2017
Drug Giants Making Googly Eyes At 2 Small Biotechs 9/21/2017
Once-Prominent Bay Area Biotech VC, Steven Burrill, Faces Up to 30 Years in Prison 9/21/2017
Nestle's Galderma Laboratories to Slash Up to 450 Jobs at R&D Center 9/21/2017
Sanofi (SNY) R&D Boss Thinks His Team is Ready to Survive Without Besties Regeneron (REGN) and Alnylam (ALNY) 9/21/2017
Famed Genomics Pioneer's Synthetic Genomics Hit With Gender Discrimination Lawsuit by Former VP 9/21/2017
Eli Lilly (LLY) Heads to Finish Line with Breast Cancer Treatment Abemaciclib 9/21/2017
Why Struggling MannKind (MNKD) is Struggling No More 9/21/2017
Alnylam (ALNY) Stock Catapults as Genetic Disease Drug Meets All Phase III Goals 9/21/2017
New Kid on the Block Provention Bio Snags 2 Clinic-Ready Immune Compounds From Johnson & Johnson (JNJ) 9/21/2017
Rodin Nabs $27 Million to Carry HDAC Complex Compound into the Clinic 9/21/2017
Bay Area Startup Arcus Biosciences Lands $307 Million+ Deal With Taiho Pharma 9/21/2017
Harvard Biotech Guru, VCs Launch LifeMine With $55 Million Series A 9/20/2017
Biotech Startup Bonanza Continues as Disarm Therapeutics Emerges With $30 Million 9/20/2017
Roche (RHHBY) Slammed With Partial Holds for Two Combo Cancer Trials 9/20/2017
Tiny Massachusetts Biotech Corbus (CRBP) to Triple HQ Space to Accommodate Growth 9/20/2017
Why Exiting the Generics Biz or a Break Up Could Save Troubled Teva (TEVA) 9/20/2017
How Gilead (GILD)'s $12 Billion Kite Pharma (KITE) Deal Has Already Paid Off for Investors 9/20/2017
Growing Catalent (CTLT) Takes Out Cook Pharmica in $950 Million Deal 9/20/2017
Booming Rho to Go on 40-Person+ Hiring Binge 9/20/2017
Boston's Juniper Pharma Suspends Program, Cuts 8% of R&D Jobs and CMO Steps Down 9/20/2017
3 California Biotechs That Have Already Gained 300% or More This Year 9/20/2017
Former GlaxoSmithKline (GSK) CEO and R&D Boss Secure New Gigs at Biotech VC Firms 9/19/2017
Johnson & Johnson (JNJ)-Backed Science Project to Create Champions of Science, Challenge Stereotypes 9/19/2017
Nabriva (NBRV)'s Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials 9/19/2017
Bill & Melinda Gates Foundation Sinks $40 Million Into Immunocore for Infectious Disease R&D 9/19/2017
Bay Area's Ultragenyx (RARE) Swoops in With $138 Million Bid for Almost-Sold Dimension Therapeutics (DMTX) 9/19/2017
Kaleido Biosciences Emerges From Stealth Mode With $65 Million and Will be Helmed by Fomer Cubist (MRK) Exec 9/19/2017
San Diego's Halozyme (HALO) Lands Monster R&D Deals Worth $2 Billion+ From Bristol-Myers Squibb (BMY) and Roche (RHHBY) 9/19/2017
Amgen (AMGN), Allergan (AGN) Make History With First Cancer Biosimilar OK—Will Take on Genentech (RHHBY)'s $6 Billion Best-Seller 9/18/2017
Show Me The Money: Bay Area’s Top 5 Venture Capital-Backed Biotechs 9/18/2017
Massachusetts' Flexion (FLXN) Terminates R&D Deal With AstraZeneca PLC (AZN) 9/18/2017
Debt-Ridden Teva (TEVA) Gets Ready to Unload Another Asset Worth $800 Million 9/15/2017
This Regeneron (REGN) Drug Just Took Another Step Toward Blockbuster Status 9/15/2017
Bavarian Nordic (BAVA.CO) Plummets 49% After Cancer Vaccine Flunks Late-Stage Test 9/15/2017
14 Women Land Board Positions Through Women in Bio, LifeSci Initiatives 9/15/2017
Hawaii's Boom in Biotech Jobs Lures Top Graduates 9/15/2017
Scientists: Is a Master’s Degree the New Bachelor’s Degree? 9/15/2017
Novartis AG (NVS) Unloads Former New York Space for $18 Million, Resold for $30 Million 9/15/2017
New Career Path Emerges in Immuno-Biotechnology 9/15/2017
Secretive Moderna Shakes Up R&D Model, Shows Off Early-Stage Trial Data 9/15/2017
FDA Calls Regeneron (REGN), Sanofi (SNY) Carcinoma Drug a Breakthrough 9/15/2017
Pharma Bro Shkreli Gets Locked Up Over Bizarre Facebook Stunt 9/14/2017
Otonomy (OTIC) Slashes 33% of Staff After Failed Phase III Clinical Trial for Meniere’s Disease 9/14/2017
AstraZeneca PLC (AZN) Offloads Remaining Anesthetics Portfolio in $766 Million Deal 9/14/2017
Through M&A, These 2 Biotechs Could Help a Refreshed Alexion (ALXN) Build Its Pipeline 9/14/2017
Bay Area Startup BridgeBio Quietly Snags $135 Million From a Bunch of Wall Street Firms 9/14/2017
Amicus (FOLD) Dumps Lead Rare Disease Drug After Phase III Trial Failure 9/14/2017
Vertex (VRTX)’s Terminated Phase II CF Trial Was Planned 9/13/2017
Johnson & Johnson (JNJ) Quits Multibillion-Dollar Hep C Drug Program, Partners' Stocks Fall 9/13/2017
LakePharma Opens New Facility in Bay Area's 'Birthplace of Biotechnology' 9/13/2017
Cytel to Hire 100+ Biostatisticians, Statistical Programmers and Data Managers in Expansion 9/13/2017
Alexion (ALXN) Wants a Fresh Start, Slashes 20% of Jobs and Will Move HQ to Boston 9/13/2017
SAGE Therapeutics (SAGE) Crashes Hard as Lead Epilepsy Drug Flunks Phase III Test 9/13/2017
Two Deaths Hit AbbVie (ABBV)'s Late-Stage RA Study 9/13/2017
Why This Bay Area Biotech Could be a Cash Cow for Investors 9/13/2017
Gecko Biomedical is Expanding Following Marketing Approval of its Vascular Sealant 9/12/2017
ProQR Therapeutics (PRQR) Spins Out CNS-Focused Biotech, Amylon Therapeutics 9/12/2017
Onxeo (ONXEO.PA) Plunges After Liver Cancer Drug Fails Late-Stage Study 9/12/2017
FDA's Gottlieb Has Big Plans to Get Drugs Approved Faster, Tackle Drug Development Costs 9/12/2017
The Search is Over: Struggling Teva (TEVA) Finally Gets a New CEO 9/11/2017
2 Biotechs That Could be the Next M&A Targets 9/11/2017
Unknown Number of Employees Impacted as ESSA Pharma Restructures and Refocuses R&D 9/11/2017
Eli Lilly (LLY) Chops 3,500 Jobs, Shuts Down 2 R&D Sites 9/11/2017
Genentech (RHHBY)'s Macular Degeneration Candidate Flunks Phase III Study 9/11/2017
Patient Dies in Cellectis (CLLS)' Groundbreaking CAR-T Trial, Forcing a Halt to Trials 9/11/2017
Exiting Novartis AG (NVS) CEO Sets His Sights on Silicon Valley and Its Biotech Startups 9/11/2017
FDA Berates Pfizer (PFE) Unit for EpiPen Misfires During 'Life-Threatening Emergencies' 9/8/2017
Massachusetts' Replimune Lands $55 Million, Taps Cancer Pioneer as CMO 9/8/2017
FDA Orders 6 Partial or Full Clinical Holds on Celgene (CELG)'s Blood Cancer Studies 9/8/2017
134 Employees Impacted as Elanco Consolidates 9/8/2017
Merck & Co. (MRK) Takes Out Immuno-Oncology Startup in $603 Million Deal 9/8/2017
Patient Death Forces Alnylam (ALNY) to Suspend Dosing in Hemophilia Trial, Stock Plunges 9/8/2017
FDA Slaps Partial Hold on 3 of Bristol-Myers Squibb (BMY)'s Opdivo-Based Combo Trials 9/8/2017
After a Billion+ Loss to Alzheimer's at Medivation (MDVN), Hung Takes Another Shot at Ramaswamy's Axovant (AXON) 9/8/2017
Google (GOOG) Gets in on Bay Area Gritstone Oncology's $92.7 Million Series B Boost 9/8/2017
Hiring Now: Dow Development Laboratories Takes More Space in the Bay Area 9/7/2017
7 PDUFA Dates to Mark on Your Calendars for September 9/7/2017
Verastem (VSTM) Soars as Blood Cancer Drug Succeeds in Phase III Study 9/7/2017
Work/Life Balance in the Life Sciences: Not as Bad as You Think 9/7/2017
Tiny Bicycle Therapeutics Wrangles a $424 Million R&D Pact With Biogen (BIIB) Spinoff Bioverativ (BIVV) 9/7/2017
Surprise Exit: Novartis AG (NVS) CEO to Retire and Return to Silicon Valley, R&D Head Named New Leader 9/7/2017
How Gilead (GILD) and Kite Pharma (KITE)'s Flirtation Became the Real Thing 9/6/2017
Meet the 4 VC-Backed Biotech Startups That Just Landed Space in Kendall Square 9/6/2017
Troubling Times for Shire (SHPG) as Execs Jump Ship and Employee Satisfaction is at an All Time Low 9/6/2017
Takeda (TKPYY) Jumps Into the Land of CAR-T R&D With New Tie-Up 9/6/2017
Insmed (INSM) Rockets as Lung Drug Wows in Late-Stage Study 9/6/2017
Many Employees Moved to Boston as Part of Takeda (TKPYY)'s Transformation 9/5/2017
Meet the Stanford and USC Dropouts Whose Blood-Testing Startup 'Isn't the Next Theranos' 9/5/2017
SoCal's Cytori (CYTX) Pink Slips 50% of Workforce in Restructuring 9/5/2017
For Sale: Merck KGaA (MKGAF.PK) Healthcare Business, Slightly Used, $1Billion-Plus Value 9/5/2017
Johnson & Johnson (JNJ) Dissolves $700 Million R&D Deal With MacroGenics (MGNX) 9/5/2017
Why Bristol-Myers Squibb (BMY) Could be the Answer to Pfizer (PFE)'s Pipeline Woes 9/5/2017
Scandal-Ridden Proove Biosciences Sells Assets, Founder and CEO Exits Amid Allegations 9/5/2017
Why Gilead (GILD) Could Take Out Juno (JUNO) But Face Major Competition From This Biotech Giant 9/1/2017
Novartis AG (NVS) Waltzes to the Finish Line With First Ever FDA Approval for CAR-T 9/1/2017
Effective Today: Cancer Biotech ImMAGE (IMMG) Shutters Operations 9/1/2017
Investors Wait with Bated Breath for AstraZeneca PLC (AZN)'s Cancer Trial Data Next Week 9/1/2017
Former Celator (CPXX) CPA Connived With Two Friends, Father on Insider-Trading Scheme 9/1/2017
Incyte (INCY) Discloses Promising New Data in Combo Drug Trial With Merck & Co. (MRK)'s Keytruda 9/1/2017
Daiichi Sankyo Terminates $650 Million Deal With This U.S. Pharma 9/1/2017
Rumor Alert: Struggling AstraZeneca PLC (AZN) Made a Pass at This $16 Billion Japanese Drugmaker Last Year 9/1/2017
Why This Tiny Biotech is Giving Cash to Amgen (AMGN) Researchers 9/1/2017
Fired Pfizer (PFE) Scientist Slated for 2 More Retractions, Bringing the Total to 7 9/1/2017
Daiichi Sankyo Denies AstraZeneca PLC (AZN) Courtship 8/31/2017
Cambrex Corporation (CBM) to Hire a Dozen New R&D Scientists in Expansion 8/31/2017
Five Prime (FPRX) Terminates $460 Million Immuno-oncology Deal With This SoCal Biotech 8/31/2017
Integral Molecular Doubles Employee Headcount in Facility Expansion 8/31/2017
Allergan (AGN) is Laying Off 109 Employees in SoCal, Effective October 23 8/31/2017
Otonomy (OTIC) Suspends Development of Lead Drug After Phase III Flop, Stock Plunges 8/31/2017
Cancer Startup Torque Therapeutics Nabs $21 Million and Sets Up Shop in Kendall Square 8/31/2017
Longtime Biogen (BIIB) Exec Jumps Ship to Become COO of Scangos' Bay Area Startup 8/30/2017
BioPharm Executive: What Could Trump's Meltdown Mean for Biotech? 8/30/2017
Royal Philips Electronics N.V. (PHG) to Bring 800 New Jobs to Nashville 8/30/2017
Jazz Pharma (JAZZ) Bets $175 Million on This Massachusetts Biotech's Antibody-Drug Program 8/29/2017
Acorda (ACOR) Plunges After the FDA Rejects Marketing App for Parkinson's Disease Drug 8/29/2017
InVivo Therapeutics (NVIV) Slashes 39% of Jobs and Cuts Two R&D Programs in Restructuring 8/29/2017
Enumeral Biomedical (ENUM) Gets Evicted as it Winds Down Operations 8/29/2017
A First: Novartis AG (NVS) Drug May Prevent Heart Attacks and Cut Lung Cancer Risk Too 8/29/2017
CSL Behring Scoops Up This U.S. Biotech for $416 Million 8/29/2017
Biogen (BIIB) Shows Off More Positive Alzheimer’s Trial Data 8/29/2017
Gilead (GILD) Goes Big, Pays $11.9 Billion for This SoCal CAR-T Biopharma 8/28/2017
Elon Musk's Biotech Quietly Nabs $27 Million to Stick Machines Into People's Brains 8/28/2017
Big-Name Investor Peter Thiel Funds ‘Unethical’ Offshore Herpes Vaccine Trial 8/28/2017
Pfizer (PFE) Picks Dramatic Skyscraper for Its New HQ in the Big Apple 8/25/2017
The FDA Calls Kyowa Hakko's Lymphoma Drug a Breakthrough 8/25/2017
Troubled Dimension Therapeutics (DMTX) Sold in All-Stock Deal 8/25/2017
Novartis AG (NVS) Pays $31 Million+ for XOMA  (XOMA)'s Failed Phase III Drug 8/25/2017
Former Schering-Plough (SGP) CEO Says This is the 'Worst Solution' to the Drug Pricing Dilemma 8/25/2017
Adamas (ADMS) Wins FDA OK for the First and Only Drug for Parkinson's Dyskinesia Drug 8/25/2017
Massachusetts Startup sRNAlytics Develops Potent Small RNA Biomarker Sequencing Data 8/25/2017
Boston's Paratek (PRTK) Heads to The Auction Block 8/24/2017
Altimmune Expands to New HQ With Plans for New Jobs 8/24/2017
This Pharma Giant Doesn't Want Its Drug Used in Death Penalty Executions 8/24/2017
Job Cuts and Facility Reductions Loom Over SoCal's ImmunoCellular (IMUC) 8/24/2017
2 Biotechs Billionaires are Loading Up on in 2017 8/24/2017
Biotech Gene Therapy Startup Apic Bio Launches in Cambridge, Massachusetts 8/24/2017
Meet the 23-Year-Old Who's Gambling $22 Million on Anti-Aging R&D 8/24/2017
This Drug Could be the Most Crucial in Regeneron (REGN)'s Massive Pipeline 8/24/2017
The Not So Hidden Costs of NIH Budget Cuts Drag Down PhDs 8/24/2017
Illumina (ILMN) Spins Out Forensic Genetics Business Into New Company, Verogen 8/24/2017
Seattle's Omeros (OMER) Fires Back But Still Won't Answer Basic Questions About Key Drug 8/24/2017
How Roche (RHHBY) Fine-Tuned an Old Drug Under a New Name to Keep Making Profits 8/24/2017
Ionis Pharma (IONS) Urges Investors to Reject the Below-the-Market Offer By TRC Capital 8/24/2017
Shire (SHPG) CFO Quits for Boston-Based Microbiome Startup 8/22/2017
Look Out Biotechs, Ambitious Plans Emerge for New York’s Next Life Science Center 8/22/2017
These 3 Biotechs Could Have the Most Exciting Late-Stage Cancer Candidates 8/22/2017
Why This Massachusetts Biotech Could be the Tesla of Healthcare 8/22/2017
New Jersey Startup Celularity Launches With Clinical Assets From Big Name Biotechs 8/22/2017
Sarepta (SRPT)’s Exondys 51 Saga Continues as More Details About FDA’s Criticism Uncovered 8/22/2017
Gene Therapy Firm Krystal Biotech Files for $35 Million IPO 8/22/2017
How Roche (RHHBY)'s $300 Million Campus Transformation Targets the New Generation of Biotech Workers 8/22/2017
Mystery Phoenix-Based Biotech Nixes Relocation Plans But Seeks M&A 8/22/2017
3 Hot Biotech Stocks That Cost Less than a Cup of Coffee 8/21/2017
Biosimilars Giant Takes the Plunge Into Original Biotech Drugs Via Takeda (TKPYY) Deal 8/21/2017
Biotech Startups Flock to the Suburbs Over Rising Rent Prices 8/21/2017
AstraZeneca PLC (AZN) Jumps Deeper Into mRNA Drugs With Ethris Deal 8/21/2017
Heads Up Tesaro (TSRO): AstraZeneca PLC (AZN), Merck & Co. (MRK)'s Ovarian Cancer Drug Just Got Expanded Use From the FDA 8/18/2017
FDA Green Lights Pfizer (PFE) Drug for Rare, Fast-Killing Type of Leukemia 8/18/2017
Long-Time NIH Scientist to Head Up Early Discovery at Pfizer (PFE) Unit 8/18/2017
Meet the BioPharma Vet Frantically Raising Cash for His Biotech Startup Engage Therapeutics 8/18/2017
LifeNet to Create Hundred of New Jobs in Virginia Through HQ Expansion 8/18/2017
The 3 Absolute Best Biotech Stocks Right Now 8/18/2017
Biogen (BIIB) Gained $1 Billion Overnight After Becoming Goldman Sachs' Favorite Biotech 8/17/2017
Johnson & Johnson (JNJ) CEO Backpedals and Quits Right Before Trump Disbands Council 8/17/2017
Arcus Biosciences, Wuxi Biologics Hammer Out R&D Cancer Pact Worth $816 Million+ 8/17/2017
Novo Nordisk A/S (NVO)’s Diabetes Drug Beats Out Eli Lilly (LLY)’s Trulicity in Phase III Trials 8/17/2017
Novartis AG (NVS) Lures Superstar Scientist Away From UCSF 8/17/2017
This is What Happens When the FDA Approves Cancer Drugs Too Quickly 8/17/2017
How Eli Lilly (LLY) Allegedly Used a Fake Rule and Fake News to Protect Bad Patents 8/16/2017
Bristol-Myers Squibb (BMY)'s Stock Topples as Kidney Cancer Drug Flunks Phase III Study 8/16/2017
Jounce (JNCE) Names Ex-Ariad (ARIA)'s Top Dealmaker as Its New CBO 8/16/2017
Gilead (GILD) to Unveil New SoCal Facility That Could House Up to 500 Employees 8/16/2017
Why Gilead (GILD) Might Not Make an Oncology Buy After All 8/16/2017
Struggling Teva (TEVA) Seeks Partners to Fund Some Projects in Its Drug Pipeline 8/16/2017
Sihuan Pharma Opens Up R&D Shop in the San Francisco Bay Area 8/15/2017
FDA Puts in Place New Hiring Protocols for Foreign Scientists 8/15/2017
Merck & Co. (MRK) CEO Resigns From President Trump's American Manufacturing Council by Tweet 8/15/2017
As Its CEO Retires, Cerecor (CERC) Divests Depression Drug to Pharma Giant in $45 Million Deal 8/15/2017
Pharma Giant Bristol-Myers Squibb (BMY) Plans Layoffs, Effective Oct. 6 8/15/2017
Ophthotech (OPHT)'s Wet AMD Drug Fails to Meet Primary Endpoint in Phase III Study 8/15/2017
CRISPR’s Bright Future, Real Science and the Science Fiction of Designer Babies 8/15/2017
What You Need to Know About Merck & Co. (MRK)'s Fearless CEO Ken Frazier 8/15/2017
Amazon (AMZN)'s Possible Strategy for Breaking Into the $560 Billion Pharma Market 8/15/2017
Vicarius Pharma Launches With $21.8 Million and Will be Helmed by Former Biogen (BIIB)-Elan (ELN) Exec 8/15/2017
Biotech Startup Prelude Therapeutics Gets Grant to Triple Its Workforce 8/15/2017
Warning for Scientists: Scammers are Giving Away NIH Grants 8/15/2017
Tiny Virtual Biotech CellAct Forges $250 Million Chemo R&D Pact With Mundipharma 8/15/2017
Galapagos (GLPG.BR)' Phase II Results With GLPG1690 are 'Extremely Exciting' 8/14/2017
Former Pfizer (PFE) Scientist-Led Startup Zai Lab Taps Banks for $150M IPO 8/14/2017
130 Jobs Affected as Merck KGaA (MKGAF.PK) Relocates Accounting, Book-Keeping Team to Cut Costs 8/14/2017
Bleeding Money, Patrick Soon-Shiong’s NantHealth (NH) Restructures and Lays Off 300 8/14/2017
Novogen (NVGN) Restructures, Board to Take Pay Cuts 8/14/2017



//-->